Skip to main content
SpringerLink
Log in

Gender Differences in Parkinson’s Disease

  • Chapter
  • First Online:
Neurology and Psychiatry of Women

  • 1174 Accesses

Abstract

Parkinson’s disease, a degenerative neurologic condition, manifests itself differently in women than in men. Women are less likely to develop the disease and, when they do develop it, have a later onset than men. This chapter looks at a number of factors that may impact how the disease affects women differently than men including how genetic and hormonal differences may play a role. The expression of the disease, both motor and nonmotor symptoms, tends to be different in men and women also and treatment may be impacted by these differences. Finally, the data regarding pregnancy in Parkinson’s disease patients is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 79.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dexter DT, Jenner P. Parkinson’s disease from pathology to molecular disease mechanisms. Free Radic Biol Med. 2013;62:132–44.

    Article  CAS  Google Scholar 

  2. Haaxma CA, Bloem BR, Borm GT, et al. Gender differences in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78:819–24.

    Article  Google Scholar 

  3. Wooten GF, Currie LJ, Boubjerg VE, et al. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637–9.

    Article  CAS  Google Scholar 

  4. Van Den Eeden SK, Tanner CM, Bernstein AL, et al. Incidence of Parkinson’s disease: variations by age, gender and race/ethnicity. Am J Epidemiol. 2003;157:1015–22.

    Article  Google Scholar 

  5. Shulman LM, Bhat V. Gender disparities in Parkinson’s disease. Expert Rev Neurother. 2006;6:407–16.

    Article  CAS  Google Scholar 

  6. Martinez-Martin P, Falup P, Odin P, et al. Gender-related differences in the burden of nonmotor symptoms in Parkinson’s disease. J Neurol. 2012;259:1639–47.

    Article  Google Scholar 

  7. Semchuk KM, Love EJ, Lee RG. Parkinson’s disease and exposure to agricultural work and pesticide chemicals. Neurology. 1992;42:1328–35.

    Article  CAS  Google Scholar 

  8. Bruns J, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia. 2003;44(suppl.10):2–10.

    Article  Google Scholar 

  9. Czech DP, Lee J, et al. The human testis-determining factor SRY localizes in midbrain dopamine neurons and regulates multiple components of catecholamine synthesis and metabolism. J Neurochem. 2012;122:260–71.

    Article  CAS  Google Scholar 

  10. Benedetti MD, Maraganore DM, et al. Hysterectomy, menopause and estrogen use preceding Parkinson’s disease: an exploratory case control study. Mov Disord. 2001;16:830–7.

    Article  CAS  Google Scholar 

  11. Currie LJ, Harrison MB, et al. Postmenopausal estrogen use affects risk for Parkinson’s disease. Arch Neurol. 2004;61:886–8.

    Article  Google Scholar 

  12. Liu B, Dluzen DE, et al. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson’s disease. Clin Exp Pharmacol Physiol. 2007;34:555–65.

    Article  CAS  Google Scholar 

  13. Rocca WA, Bower JH, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008;70:200–9.

    Article  CAS  Google Scholar 

  14. Sandyk R. Estrogens and the pathophysiology of Parkinson’s disease. Int J Neurosci. 1989;45:119–22.

    Article  CAS  Google Scholar 

  15. Rodriguez-Navarro JA, Solano RM, et al. Gender differences and estrogen effects and parkin null mice. J Neurochem. 2008;106:2143–57.

    Article  CAS  Google Scholar 

  16. Gillies GE, Murray HE, et al. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson’s disease. Pharmacol Biochem Behav. 2004;78:513–22.

    Article  CAS  Google Scholar 

  17. McArthur S, Murray HE, et al. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition. Neuropsychopharmacology. 2007;32:1462–76.

    Article  CAS  Google Scholar 

  18. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 1997;767:340–4.

    Article  CAS  Google Scholar 

  19. Ferraz AC, Matheussi F, et al. Evaluation of estrogen neuroprotective effect on nigrostriatal dopaminergic neurons following 6-hydroxydopamine injection into the substantia nigra pars compacta or the medial forebrain bundle. Neurochem Res. 2008;33:1238–46.

    Article  CAS  Google Scholar 

  20. Gillies GE, Pienaar IS, et al. Sex differences in Parkinson’s disease. Front Neuroendocrinol. 2014;35:370–84.

    Article  CAS  Google Scholar 

  21. Hariz GM, Lindberg M, et al. Gender differences in disability and health-related quality of life in patients with Parkinson’s disease treated with stereotactic surgery. Acta Neurol Scand. 2003;108:28–37.

    Article  Google Scholar 

  22. Baba Y, Putzke JD, et al. Gender and Parkinson’s disease phenotype. J Neurol. 2005;252:1201–5.

    Article  Google Scholar 

  23. Accolla E, Caputo E, et al. Gender differences in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Mov Disord. 2007;22:1150–6.

    Article  Google Scholar 

  24. Zappia M, Crescibene L, et al. Body weight influences pharmacokinetics of levodopa in Parkinson’s disease. Neurol Sci. 2002;23(Suppl 2):S53–4.

    PubMed  Google Scholar 

  25. Picillo M, Palladino R, et al. Gender and non-motor fluctuations and Parkinson’s disease: a prospective study. Parkinsonism Relat Disord. 2016;27:89–92.

    Article  Google Scholar 

  26. Locascio JJ, Corkin S, et al. Relation between clinical characteristics of Parkinson’s disease and cognitive decline. J Clin Exp Neuropsychol. 2003;25(1):94–109.

    Article  Google Scholar 

  27. Davidsdottir S, Cronin-Golomb A, Lee A. Visual and facial symptoms in Parkinson’s disease. Vis Res. 2005;45(10):1285–96.

    Article  Google Scholar 

  28. Clark US, Neargardner S, Cronin-Golomb A. A visual exploration of emotional facial expressions in Parkinson’s disease. Neurophychologia. 2010;48(7):1901–13.

    Article  Google Scholar 

  29. Nicolletti A, Vaste R. Gender effect on nonmotor symptoms of Parkinson’s disease. Parkinsonism Relat Disord. 2016;35:69–74.

    Article  Google Scholar 

  30. Perrin AJ, Nosova E, et al. Gender differences in Parkinson’s disease depression. Parkinsonism Relat Disord. 2017;36:93–7.

    Article  Google Scholar 

  31. Cereda E, Cilia R, et al. Dementia in Parkinson’s disease: is male gender a risk factor? Parkinsonism Relat Disord. 2016;26:67–72.

    Article  Google Scholar 

  32. Fernandez HH, Lapane KL, et al. Gender differences in the frequency and treatment of behavior problems in Parkinson’s disease. SAGE Study Group. Systemic assessment and geriatric drug use the a epidemiology. Mov Disord. 2000;15(3):490–6.

    Article  CAS  Google Scholar 

  33. Golbe LI. Parkinson’s disease and pregnancy. Neurology. 1987;37:1245–9.

    Article  CAS  Google Scholar 

  34. Hagell P, Odin P, Vinge E. Pregnancy in Parkinson’s disease: a review of the literature and a case report. Mov Disord. 1998;13:34–8.

    Article  CAS  Google Scholar 

  35. Seier M, Hiller A. Parkinson’s disease and pregnancy: an updated review. Parkinsonism Relat Disord. 2017;40:11–7.

    Article  Google Scholar 

  36. Rosa F. Amantadine pregnancy experience. Reprod Toxicol. 1994;8:531.

    Article  CAS  Google Scholar 

  37. Nora JJ, Nora AH, Way GL. Cardiovascular maldevelopment associated with maternal exposure to amantadine. Lancet. 1975;2:607.

    Article  CAS  Google Scholar 

  38. Pandit PB, Chitayat D, Jefferie AL, Qamar IU, Koren G. Tibial hemimelia and tetralogy of Fallot associated with first trimester exposure to amantadine. Reprod Toxicol. 1994;8:89–92.

    Article  CAS  Google Scholar 

  39. Scelzo E, Mehrkens JH, Botzel K, Krack P, Mendes A, Chabardes S, et al. Deep brain stimulation during pregnancy and delivery: experience from a series of “DBS babies”. Front Neurol. 2015;6:191.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Michael T. Hayes

  2. South Shore Hospital, Weymouth, MA, USA

    Michael T. Hayes

  3. Harvard Medical School, Boston, MA, USA

    Michael T. Hayes

Authors
  1. Michael T. Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael T. Hayes .

Editor information

Editors and Affiliations

  1. Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA

    Mary Angela O’Neal

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hayes, M.T. (2019). Gender Differences in Parkinson’s Disease. In: O’Neal, M. (eds) Neurology and Psychiatry of Women. Springer, Cham. https://doi.org/10.1007/978-3-030-04245-5_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-04245-5_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-04244-8

  • Online ISBN: 978-3-030-04245-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation